Vertex Pharmaceuticals Incorporated
Crystalline forms and compositions of CFTR modulators
Last updated:
Abstract:
Crystalline Forms of Compound I: ##STR00001## and pharmaceutically acceptable salts thereof are disclosed. Pharmaceutical compositions comprising the same, methods of treating cystic fibrosis using the same, and methods for making the same are also disclosed.
Status:
Grant
Type:
Utility
Filling date:
25 Mar 2020
Issue date:
26 Oct 2021